A biofi lm is a complex community of surface-associated cells enclosed in a polymer matrix. They attach to solid surfaces and their formation can be affected by growth conditions and co-infection with other pathogens. The presence of biofi lm may protect the microorganisms from host defenses, as well as signifi cantly reduce their susceptibility to antifungal agents. Pathogenic microbes can form biofi lms on the inert surfaces of implanted devices such as catheters, prosthetic cardiac valves and intrauterine devices (IUDs). The present study was carried out to analyze the presence of biofi lm on the surface of intrauterine devices in patients with recurrent vulvovaginal candidiasis, and to determine the susceptibility profi le of the isolated yeasts to amphotericin B and fl uconazole. Candida albicans was recovered from the IUDs and it was found to be susceptible to the antifungal agents when tested under planktonic growing conditions. These fi ndings indicate the presence of the biofi lm on the surface of the IUD as an important risk factor for recurrent vulvovaginal candidiasis.
Introduction
Biofi lm is a complex structure that can be produced by various microorganisms, including members of the genus Candida . Its production varies according to the environment and the available substrate [ 1, 2 ] . Biofi lms attach to solid surfaces and their formation can be affected by growth conditions and co-infection with other microorganisms [ 3 ] . The presence of biofi lms can serve as a reservoir of microorganisms, and can also lead to resistance to antimicrobial agents [ 4, 5 ] . Although bacterial biofi lms have been studied in detail [ 6 ] , there have been few studies of medically-related fungal
Case 1
The patient was 29 years old, married,with two children and presented clinical symptoms suggestive of RVVC (presence of vaginal discharge, vulval pruritus, itching and erythema). She was found to be negative for HIV infection and diabetes mellitus. The patient had used the IUD for three years and one month as a contraceptive method and reported that the symptoms had begun soon after the implantation of the device. These symptoms had intensifi ed during the last year, primarily in terms of the pruritus and discharge. The patient mentioned that in several previous gynecological visits she had been treated with fl uconazole. During her present gynecologic examination, a sample of the secretion from the patient's vagina was collected with sterile swabs from the lateral walls of the vagina and the fundus of the vaginal sack, with the aid of an unlubricated speculum. The clinical material was freshly harvested for immediate examination in 3 ml sterile saline solution (NaCl 0.85%). The vaginal secretions were prepared on the surfaces of two sterile slides for Gram-stain. Vaginal swabs were directly inoculated onto Petri dishes containing Sabouraud dextrose agar medium (Difco, Detroit, USA) as well as on Petri dishes containing CHROMagar Candida (Paris, France) in order to facilitate the isolation of Candida spp. All the cultures were incubated for 10 days at 37°C. The IUD was removed from the patient after gynecologic and laboratory examinations. Removal of the IUD was carried out under antiseptic conditions and was performed without the IUD touching the vaginal wall or the opener instrument to prevent contamination by the vaginal fl ora. Immediately after the removal of the IUD the patient was treated orally with a single 150 mg dose of fl uconazole. Three months after removal of the IUD the patient returned for a second gynecologic examination where she did not present signs or symptoms suggestive of RVVC and laboratory examinations of vaginal secretions were negative for yeasts.
Case 2
The patient was 38 years old, married, and presented clinical symptoms suggestive of RVVC (presence of vaginal discharge with a clumpy, cottage-cheese appearance, vulval pruritus and itching). She too was found to be negative for HIV and diabetes mellitus. The patient reported that the discharge and itching had become worse over the last two years. She had been using an IUD for about fi ve years as a contraceptive method. The patient mentioned that in previous gynecological visits she had been treated with fl uconazole. During the gynecologic exam, vaginal secretions were collected with sterile swabs with the aid of an unlubricated speculum. The clinical material was freshly harvested for immediate examination in 3 ml sterile saline solution (NaCl 0.85%). The vaginal secretions were prepared on the surfaces of two sterile slides for Gram-stain. Vaginal swabs were directly inoculated onto Petri dishes containing Sabouraud dextrose agar medium (Difco, Detroit, USA), as well as on Petri dishes containing CHROMagar Candida (Paris, France) in order to facilitate the isolation of Candida spp. All the cultures were incubated for 10 days at 37°C. After the clinical and laboratory examinations the IUD was removed under antiseptic conditions and examined by scanning electron microscopy. The removal was performed without touching the IUD to the vaginal wall or the opener instrument to prevent contamination by the vaginal fl ora. Immediately after the removal of the IUD the patient was treated orally with a single 150 mg dose of fl uconazole. Three months after the removal of the IUD, the patient returned for a second gynecologic exam, where she did not present signs or symptoms suggestive of RVVC and laboratory exams of vaginal secretion were negative for yeasts.
Isolation and identifi cation of the yeasts
The yeasts isolated from the secretion samples of the patients were identifi ed on the basis of germ-tube production in fetal calf serum at 37°C for 2 h, production of chamydospores on corn-meal agar (Oxoid) containing Tween 80 (Sigma) according to the Dalmau method, assimilation of carbon sources, as recommended by Kurtzman and Fell, 1998 [ 12 ] and the use of the commercial test API 20C AUX kit (bioMérieux). For comparative purposes, Candida dubliniensis , isolates were streaked onto the surface of SDA agar (Difco, Detroit, MI, USA) plate and incubated at 42°C as previously described [ 13 ] . All isolates that were recovered were suggestive of Candida albicans and to confi rm this identifi cation, PCR studies were performed as described previously with the oligonucleotide primer specie-specifi c forward CAL5 (5′ TGT TGC TCT CTG GGG GGC GGC CG 3´) and NL4CAL (5′ AAG ATC ATT ATG CCA ACA TCC TAG GTA AA 3′) reverse primer for confi rmed Candida albicans . The American Type Culture Collection (ATCC) Candida albicans strain 90028 was used as the control. The PCR method used were performed in accord with that described by Mannarelli and Kurtzman [ 14 ] .
Scanning electron microscopy
The IDUs were washed with sterile water to remove nonadhered yeast cells. The biofi lms formed on the IDUs were fi xed with 2.5% (v/v) glutaraldehyde in 0.15 M PBS for 1 h at room temperature. They were then treated with 1% (w/v) osmium tetroxide for 1 h, washed thrice with distilled water, treated with 1% (w/v) uranyl acetate for 1 h and washed again with distilled water. The samples were then dehydrated in ethanol. All samples were dried to the critical point, submitted to gold-coat metallization, and observations were made with the JEOL-JSM 6100 scanning electron microscope (Jeol Ltda, Tokyo, Japan) at the Institute of Biomedical Sciences of the University of São Paulo, Brazil.
Susceptibility testing
The antifungal agents used in this study were amphotericin B (Sigma, St. Louis MO, USA) and fl uconazole (Pfi zer Central Research, New York, USA). Susceptibility testing was performed as described in document M27-A3 [ 15 ] . The stock solutions were prepared in water (for fl uconazole) and dimethyl sulphoxide (for amphotericin B). Further dilutions of each antifungal agent were prepared with RPMI 1640 medium 0.2% glucose (Sigma) which had been buffered to pH 7.0 with 0.165 M morpholinopropanesulfonic acid (Sigma), with L-glutamine and phenol red as outlined in document M27-A3 (2008). The drug dilutions (containing double the fi nal concentration) were dispensed into 96-well microdilution plates that were sealed and stored frozen at -70°C until the day of the test. The yeasts were subsequently subcultured on Sabouraud dextrose agar (Difco), for 24 h at 35°C prior to antifungal susceptibility testing. The inoculum was prepared for spectrophotometric analysis, conducted at 530 nm, and the yeast fi nal inoculum concentration was 0.5ϫ10 3 to 2.5ϫ10 3 CFU/ml. The plates were incubated at 35°C for 48 h in a non-CO 2 incubator. The interpretive criteria for the minimum inhibitory concentration (MIC) in the susceptibility test were those published in document M27-A3 (2008).
Results
The fi rst laboratory examination of the vaginal secretion from patient 1 did not reveal the presence of yeast cells, mycelia or motile trichomonads in the wet mount. Microscopic examination of the vaginal Gram-stained smears indicated the presence of yeasts with blastoconidia and pseudomycelia ( Fig. 8 A) . Candida albicans was identifi ed by phenotypic techniques and confi rmed by PCR methods. The fi rst laboratory exam of the vaginal secretion from patient 2 did not reveal the presence of yeast cells and motile trichomonads. Examination of Gram-stained smears demonstrated the presence of yeasts with blastoconidia ( Fig. 8 B) , which were subsequently identifi ed as Candida albicans , confi rmed by PCR method. After removal of the IUDs, yeasts could not be found on the second laboratory exams of vaginal secretions of both patients. The in vitro susceptibility test results under planktonic conditions of 
Discussion
Biofi lms are aggregates of unicellular microorganisms forming multicellular structures that adhere to surfaces [ 16 ] . Cells in biofi lms are embedded within a complex matrix that may protect the microorganisms from host defenses, as well as decrease their susceptibility to antifungal agents [ 1 ] . Pathogenic bacteria and fungi can form biofi lms on the inert surfaces of implanted devices such as catheters, prosthetic cardiac valves and IUDs, and the presence of biofi lm may constitute a source of infection for patients [ 2 ,4 ,17 ] . The use of the IUD is a highly effective, the two Candida albicans strains recovered as part of the fi rst laboratory exams revealed that they were susceptible to the antifungal agents tested. The MICs of the strain isolated from patient 1 were 0.25 μg/ml for amphotericin B and 0.5 μg/ml for fl uconazole. The MICs of the isolate from patient 2 were 0.5 μg/ml for amphotericin B and 2.0 μg/ml for fl uconazole. Fig. 1 shows the intrauterine device from patient 1 before scanning electron microscopy. The examination revealed a heterogeneous biofi lm adherent (Figs. 2 A, 2B, 3 and 4 ) on the surface of the IUD's copper coil. The analysis of the biofi lm revealed the presence of a wide variety of morphologic types of bacteria that were embedded in a fi brous matrix ( Fig. 3 ) , with various types of cells -polymorphonuclear leukocytes and fi brin. Adherent yeasts were also observed on the surface of the biofi lm ( Fig. 4 ) . show the scanning electron microscopic results with the IUD from patient 2. Again, a wide variety of morphologic types of cells and microorganisms, embedded in a fi brous matrix present on the surface of the upper coil were noted. Fig. 6 shows a network of cells of different microorganisms embedded within a cellular matrix on both intrauterine devices. These data are in agreement with those published by Pruthi et al . (2003) , who found on the IUD surface a consortium of microbes organized into biofi lms [ 2 ] . Other authors who carried out in vitro tests have observed that yeast cells can adhere strongly to the parts of the IUD and form biofi lms [ 5 ] . The data in the present study suggest that the presence of biofi lm on the patients' IUDs served as a reservoir of yeasts and contributed to recurrent infection by Candida albicans . This fact can be verifi ed by the observation of yeasts in the biofi lm through electron scanning microscopic analysis, suggesting the possibility that the majority of these microorganisms had been present on these surfaces for possibly a long time. It should be noted that analysis of the images made by electron scanning microscopy ( Figs. 5 and 6 ) of patient 2 revealed a heavier biofi lm on the surface of the upper coil as compared to that of patient 1. Most likely, the longer use of the IUD by patient cost effi cient method of preventing pregnancy. It is one of the most popular methods of contraception in the world today [ 18 ] . However, if microbial biofi lms form on the surface of IUDs, they may promote infection in a susceptible host [ 10 ] . Vulvovaginal candidiasis is a fungal infection that is extremely common and remains a signifi cant problem worldwide. Several risk factors have been indicated in regard to its etiology, but many questions remain relative to recurrent infections concerning its pathogenesis due to relapses after ceasing of therapy [ 19 ,20 ] . The present study analyzed the presence of biofi lm on the surface of IUDs as a possible risk factor for RVVC, and determined the susceptibility profi les of the yeasts isolated from these patients. The study involved two patients with clinical signs and symptoms of RVVC who used IUDs as a contraceptive method. The laboratory exam of the vaginal secretion of both patients indicated the presence of Candida albicans ( Fig. 9 ) . The scanning electron microscope revealed the presence of biofi lm with a dense multilayered 2 contributed to the formation of a larger mass of biofi lm. This effect was observed by Pal et al . [ 10 ] , who analyzed the biofi lm formation on IUDs in relation to duration of use. They found that the longer use of IUDs was associated with a greater risk of chronic infection by microorganisms [ 10 ] . The adherent yeasts observed in Figs. 4 and 7 suggest that these microorganisms present on the surface of the upper coil may constitute a source of infection for patients with vulvovaginal candidiasis.
In the present study, three months after the removal of the IUD the patients returned for a new gynecological and laboratory exam, which did not reveal clinical signs or symptoms suggestive of RVVC. In addition, the laboratory data at this time were negative for Candida albicans , suggesting that the absence of the biofi lm on the surface of the IUD contributed to the absence of infection. It is important to underscore that although the treatment with fl uconazole aided in the cure, the absence of the source of the microorganisms contained in the biofi lm was essential to avoid the relapses of vulvovaginal candidiasis in these patients.
In the present study, analysis of the data revealed that all of the recovered isolates were susceptible to the two antifungals studied when tested under planktonic growing conditions. The presence of the biofi lm on the surface of the IUD contributed to protecting the yeasts from the action of the antifungal agent, while also contributing to the microorganism's persistence, leading to recurrent infections by vulvovaginal candidiasis.
In conclusion, biofi lms are a complex matrix that can contain microorganisms forming multicellular structures that adhere to solid surfaces and may contribute to the source of infection for patients.
The present study suggests that the presence of the biofi lm on the surface of the IUD may constitute a risk factor for persistent vulvovaginal candidiasis.
